Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroporation with Bleomycin for Inoperable Colorectal Cancer
2012-001248-23Phase 2Completed
- Sponsor
- Cancer Trials Ireland
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bleomycin in colorectal cancer (CRC), sponsored by Cancer Trials Ireland. Primary endpoint: Tumor regression / reduction in volume. Started May 2014; status: completed.
02
Drugs
bleomycin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2012-001248-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001248-23.